QNRX ▲ +1.4% - Quoin Pharmaceuticals, Ltd. $QNRX - Quoin Pharmaceuticals Announces FDA Grants Rare Pediatric Disease Designation for QRX003 in Peeling Skin Syndrome Quoin Pharmaceuticals' stock rose 1.4% following the company's announcement that the FDA has granted Rare Pediatric Disease Designation for its QRX003 candidate in Peeling Skin Syndrome. The designation supports development of treatments for serious pediatric conditions and can offer certain regulatory benefits, including potential priority review vouchers upon approval. 08-SEP-2026 08:31 AM ET